Clinical Trial Update: Basal Cell Carcinomas Treated With Ablative Fractional Laser and Ingenol Mebutate [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for basal cell carcinoma treated with ablative fractional laser and Ingenol Mebutate (Phase 1/2) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma

Drugs mentioned

• Ingenol Mebutate (ingenol mebutate)

Snippet

Sponsor: Merete Haedersdal | Conditions: Carcinoma, Basal Cell | Phase 1, Phase 2 | Status: COMPLETED